Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Celsion Comments on 'Chat Room' Statements.


Business/Technology Editors

COLUMBIA, Md.--(BUSINESS WIRE)--March 3, 2000

Celsion Corporation (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB: CELN), today announced that, although it is aware that certain statements concerning the Company are being made by third parties in "chat rooms" on the world-wide-web, such statements are being made without authorization of the Company or its management. Material information concerning the Company and its business operations Business operations are those activities involved in the running of a business for the purpose of producing value for the stakeholders. Compare business processes. The outcome of business operations is the harvesting of value from assets  are reported in the Company's filings with the Securities and Exchange Commission and through press releases or other announcements issued by the Company from time to time.

About Celsion

Celsion Corporation is a research and development company dedicated to commercializing medical treatment systems for cancer and other diseases using focused heat technology delivered by patented microwave technology. Celsion has research or commercial associations with leading institutions such Duke University, Harbor UCLA Medical Center UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles in Los Angeles, California. It is rated as one of the top three hospitals in the United States and is the top hospital on the West Coast according to US News & World Report. , MIT MIT - Massachusetts Institute of Technology , and Montifiore Medical Center.

Forward-looking statements in this release are made pursuant to the "safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, possible changes in cost of materials, expense items, capital expenditures, capital structure, and other financial items; introduction of new products and possible acquisitions of assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission 10220-I Old Columbia Road, Columbia MD 21046-1705 (410) 290-5390 FAX: (410) 290-5394
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 3, 2000
Words:243
Previous Article:SyCoNet.com's President And CEO Sy Picon Interviewed By WallStreetReporter.com.
Next Article:OptionInvestor.com Announces Investment Opinion.
Topics:



Related Articles
Celsion Presents Preliminary Breast Cancer Treatment Results at 56th Annual Cancer Symposium, Society of Surgical Oncology.
Celsion Files Final Clinical Module of BPH 800 PMA Submission.
Celsion Changes Fiscal Year End.
Celsion Receives Milestone Payments and Treats First Patients with Prolieve.
Celsion Submits Response to FDA Warning Letter.
Celsion to Present at RedChip Resources Discovery Day Conference 2004.
Celsion Corporation Announces Patent Infringement Suit Filed by American Medical Systems, Inc.
Celsion Corporation Resumes Shipment of Prolieve Thermodilatation(R) Catheter Kits.
Celsion Corporation Successful in Having American Medical Systems, Inc. Patent Infringement Suit Dismissed in Minnesota.
Butcher, Kristin. Chat room.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles